Dr. Fiona Simpkins, MD
Claim this profileJordan Center for Gynecologic Oncology at Penn Perelman Center for Advanced Medicine
Studies Ovarian Cancer
Studies Serous Carcinoma
5 reported clinical trials
12 drugs studied
Area of expertise
1Ovarian Cancer
ARID1A positive
ARID1A negative
MSI-H positive
2Serous Carcinoma
BRCA positive
HRD positive
BRCA negative
Affiliated Hospitals
Clinical Trials Fiona Simpkins, MD is currently running
M1774 + ZEN-3694
for Ovarian and Endometrial Cancer
This phase Ib trial tests the safety, side effects, and best dose of M1774 when given with ZEN-3694 in treating patients with ovarian and endometrial cancer that has come back (recurrent). M1774 and ZEN-3694 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. M1774 and ZEN-3694 combined together has demonstrated to be better than either drug alone in killing ovarian tumor cells.
Recruiting1 award Phase 115 criteria
ZN-c3
for Serous Carcinoma
This is a multi-part Phase 2 study to evaluate the efficacy and safety of azenosertib (ZN-c3) in subjects with Platinum-Resistant, High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer. Part 2 of the study will be conducted in subjects whose tumors are Cyclin E1 positive as determined by central review using the Sponsor's investigational clinical trial assay.
Recruiting1 award Phase 21 criteria
More about Fiona Simpkins, MD
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Fiona Simpkins, MD has experience with
- BET Bromodomain Inhibitor ZEN-3694
- Biopsy
- Biospecimen Collection
- Computed Tomography
- Electrocardiography
- Magnetic Resonance Imaging
Breakdown of trials Fiona Simpkins, MD has run
Ovarian Cancer
Endometrial Cancer
Uterine Cancer
Endometrial Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Fiona Simpkins, MD specialize in?
Fiona Simpkins, MD focuses on Ovarian Cancer and Serous Carcinoma. In particular, much of their work with Ovarian Cancer has involved ARID1A positive patients, or patients who are ARID1A negative.
Is Fiona Simpkins, MD currently recruiting for clinical trials?
Yes, Fiona Simpkins, MD is currently recruiting for 3 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Fiona Simpkins, MD has studied deeply?
Yes, Fiona Simpkins, MD has studied treatments such as BET Bromodomain Inhibitor ZEN-3694, Biopsy, Biospecimen Collection.
What is the best way to schedule an appointment with Fiona Simpkins, MD?
Apply for one of the trials that Fiona Simpkins, MD is conducting.
What is the office address of Fiona Simpkins, MD?
The office of Fiona Simpkins, MD is located at: Jordan Center for Gynecologic Oncology at Penn Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania 19104 United States. This is the address for their practice at the Jordan Center for Gynecologic Oncology at Penn Perelman Center for Advanced Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.